21 insiders have filed at NVST since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Keel Paul A | Chief Executive Officer | 384.4k | 0.231% | 1 buys $506k | |
| Aghdaei Amir | Chief Executive Officer | 310.6k | 0.187% | 4 buys $215k | |
| Hammes Eric D. | Chief Financial Officer | 110.8k | 0.067% | 1 buys $401k | |
| Nance Mark E | General Counsel | 81.3k | 0.049% | 1 buys $109k | |
| Hulit Barbara B. | Director | 79.8k | 0.048% | ||
| Eriksson Patrik | Senior Vice President | 79.7k | 0.048% | ||
| Huennekens R Scott | Director | 69.5k | 0.042% | ||
| Nilsson Stefan | President, Nobel Biocare | 62.4k | 0.037% | ||
| Kaabi Faez C | Chief Accounting Officer | 58.6k | 0.035% | ||
| Acurio Veronica | President, Orthodontics | 56.5k | 0.034% | ||
| Keller Stephen | Principal Financial Officer | 53.8k | 0.032% | 1 buys $43k | |
| Conley Eric | SVP, Orthodontics | 53.2k | 0.032% | 3 buys $50k | |
| Befidi Robert | President, Diagnostics | 50.9k | 0.031% | ||
| Carruthers Wendy | Director | 50.6k | 0.03% | ||
| Tsingos Christine A | Director | 50.6k | 0.03% | ||
| Gallahue Kieran | Director | 44.7k | 0.027% | ||
| Raskas Daniel | Director | 44.7k | 0.027% | ||
| Yu Howard H | Chief Financial Officer | 43.9k | 0.026% | ||
| Jain Vivek | Director | 43.6k | 0.026% | ||
| Reis Mischa | SVP, Strategy & Bus. Dev. | 35.3k | 0.021% | 3 sells $614k | |
| Pierce James Andrew | Director | 9.2k | <0.01% |
Full register at boothcheck.com/insiders/NVST. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.